Home
Research
Microarray Services
Publications
Presentations
Research Support
People
Site Map
|
Dec 2006 - Jul 2009
- Salvucci O, Bouchard A, Baccarelli A, Deschenes J, Sauter G, Simon R, Bianchi R, Basik M.
The role of CXCR4 receptor expression in breast cancer: a large tissue microarray study. Breast Cancer Res Treat. (2006) June;97 (3) 275-83
Dec 2005 (Epub)
- Aguilar-Mahecha A, Hassan S, Ferrario C, Basik M.
Microarrays as validation strategies in clinical samples:
tissue and protein microarrays. OMICS A Journal of Integrative Biology, 2006
Fall;10 (3):311-26.
- Khambata-Ford S, Garrett CR, Metopol NJ, Basik M,
Harbison CT, Wu S, Wong TW, Huang X, Takimoto CH, Godwin AK, Tan BR, Krishnamurthi SS, Burris HA, Poplin EA, Hidalgo M, Baselga J,
Baselga J, Clark EA, Mauro DJ. Expression of epiregulin and amphiregulin
and K-RAS mutation status are associated with disease control in metastatic colorectal cancer patients treated with cetuximab.
Journal of Clin Oncol, 2007 Aug 1;25 (22):3230-7.
- Hassan S, Baccarelli A, Salvucci O, Basik M, Plasma Stromal Cell-Derived Factor (SDF)-1: Host-Derived
Marker Predictive of Distant Metastasis in Breast Cancer. Clinical Cancer Research, 2008 Jan 15;14(2) :446-54.
- Aguilar-Mahecha A, Cantin C, O'Connor-McCourt M, Nantel A, Basik M,
Development of reverse phase protein microarrays for the validation of clusterin, a mid-abundant blood biomarker.
Proteome Sci. 2009 Apr 6;7(1):15. [Epub ahead of print]
- Hamel S, Bouchard A, Ferrario C, Hassan S, Aguilar-Mahecha A, Buchanan M, Quenneville L, Miller W, Basik M,
Both t-Darpp and DARPP-32 can cause resistance to trastuzumab in breast cancer cells and are frequently expressed in primary breast cancers.
Breast Cancer Res Treat. 2009 Mar 20
- Hassan S, Ferrario C, Saragovi U, Quenneville L, Gaboury L, Baccarelli A, Salvucci O, Basik M,
The influence of tumor-host interactions in the SDF-1/CXCR4 ligand/receptor axis in determining metastatic risk in breast cancer.
Am J Pathol. 2009 Jul;175(1):66-73. Epub 2009 Jun 4.
|